The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
Margaret M. Faul
Advertisement
Margaret M. Faul is vice-president, Drug Product Technologies, Process Development, Amgen.
Articles by Margaret M. Faul
Advertisement
Latest Updated Articles
Advertisement
Advertisement